Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kousuke Baba

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Biomolecules|April 27, 2024
Elevated Serum Xanthine Oxidase and Its Correlation with Antioxidant Status in Patients with Parkinson's DiseaseRatna Dini Haryuni, Takamasa Nukui, Jin-Lan Piao, et al.
FEBS Open Bio|December 10, 2020
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplicationHayato Fukusumi, Kazuyuki Togo, Miho Sumida, et al.
Internal Medicine (Tokyo, Japan)|August 23, 2023
Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse EventsTomokazu Seki, Kousuke Baba, Tomohiro Hayashi, et al.
Neurochemistry International|November 25, 2024
Accelerated senescence exacerbates α-synucleinopathy in senescence-accelerated prone 8 mice via persistent neuroinflammationHiroshi Sakiyama, Kousuke Baba, Yasuyoshi Kimura, et al.
Human Molecular Genetics|August 24, 2018
In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's diseaseTakeshi Uenaka, Wataru Satake, Pei-Chieng Cha, et al.
Internal Medicine (Tokyo, Japan)|January 3, 2024
Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by AtezolizumabRyoko Shibuya, Kousuke Baba, Risako Furuta, et al.
Scientific Reports|May 22, 2019
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's diseaseTakuya Uehara, Chi-Jing Choong, Masayuki Nakamori, et al.
Journal of Neuroscience Methods|April 5, 2019
MarmoDetector: A novel 3D automated system for the quantitative assessment of marmoset behaviorTaiki Yabumoto, Fumiaki Yoshida, Hideaki Miyauchi, et al.
Cellular and Molecular Neurobiology|March 31, 2004
Role of ARF4L in recycling between endosomes and the plasma membraneTaiichi Katayama, Kazunori Imaizumi, Takunari Yoneda, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2022
Erdheim-Chester Disease Involving the Central Nervous System with Latent ToxoplasmosisTomoya Wadayama, Mikito Shimizu, Ikko Kimura, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Biomolecules|April 27, 2024
Elevated Serum Xanthine Oxidase and Its Correlation with Antioxidant Status in Patients with Parkinson's DiseaseRatna Dini Haryuni, Takamasa Nukui, Jin-Lan Piao, et al.
FEBS Open Bio|December 10, 2020
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplicationHayato Fukusumi, Kazuyuki Togo, Miho Sumida, et al.
Internal Medicine (Tokyo, Japan)|August 23, 2023
Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse EventsTomokazu Seki, Kousuke Baba, Tomohiro Hayashi, et al.
Neurochemistry International|November 25, 2024
Accelerated senescence exacerbates α-synucleinopathy in senescence-accelerated prone 8 mice via persistent neuroinflammationHiroshi Sakiyama, Kousuke Baba, Yasuyoshi Kimura, et al.
Human Molecular Genetics|August 24, 2018
In silico drug screening by using genome-wide association study data repurposed dabrafenib, an anti-melanoma drug, for Parkinson's diseaseTakeshi Uenaka, Wataru Satake, Pei-Chieng Cha, et al.
Internal Medicine (Tokyo, Japan)|January 3, 2024
Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by AtezolizumabRyoko Shibuya, Kousuke Baba, Risako Furuta, et al.
Scientific Reports|May 22, 2019
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's diseaseTakuya Uehara, Chi-Jing Choong, Masayuki Nakamori, et al.
Journal of Neuroscience Methods|April 5, 2019
MarmoDetector: A novel 3D automated system for the quantitative assessment of marmoset behaviorTaiki Yabumoto, Fumiaki Yoshida, Hideaki Miyauchi, et al.
Cellular and Molecular Neurobiology|March 31, 2004
Role of ARF4L in recycling between endosomes and the plasma membraneTaiichi Katayama, Kazunori Imaizumi, Takunari Yoneda, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2022
Erdheim-Chester Disease Involving the Central Nervous System with Latent ToxoplasmosisTomoya Wadayama, Mikito Shimizu, Ikko Kimura, et al.
Pageof 6